title: Dystrophic epidermolysis bullosa: pathogenesis and clinical features.
abstract: Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.
authors: Department of Dermatology, University Medical Center Freiburg, Hauptstrasse 7, 79104 Freiburg, Germany. bruckner-tuderman@uniklinik-freiburg.de
authors: Leena
authors: L
authors: Bruckner-Tuderman
mesh_terms: D020405:Dermis / Q000473:pathology*; D004817:Epidermis / Q000473:pathology*; D016108:Epidermolysis Bullosa Dystrophica / Q000209:etiology* / Q000473:pathology* / Q000628:therapy; D006801:Humans